News

Spotlight 16/07/2018 ‘It’s coming home’

Recently there has been an increase in interest in a ‘new’ STI that is being hyped as the next new ‘superbug. We have known about Mycoplasma genitalium (aka MG or MGen) since 1980[2] when it was identified at St Mary’s Hospital.  Mgen can cause urethritis (swelling and irritation of the urethra) in men, and has […]

Spotlight 09/07/2018 Antibiotic innovation: coming home?

Antibiotic innovation: coming home? Imagine we have a time machine to take us back to the wondrous 1960s. It was a time when England won its first World Cup, and most importantly, the peak of the ‘golden age’ of antibiotic discovery. By then, more than 20 new classes of antibiotics were marketed [1] and about […]

Spotlight 02/07/2018 | $2 million grant has been received by a research team looking at new strategies to improve antibiotic dispensing in Indonesia

The Australian Government’s Indo-Pacific Centre for Health Security have granted $2 million to a research team made up of academics from Kirby Institute at UNSW Sydney, The London School of Hygiene and Tropical Medicine as well as university partners in Indonesia, allowing further research into antimicrobial resistance (AMR) in Indonesia to take place. This mixed […]

Spotlight 25/06/18 | Some shower thoughts on resistance…

…an additive of many toothpastes, hand washes and – yes – shower gels, has been shown in a new study to elicit resistance. Non-antibiotic, antimicrobial (NAAM) chemicals had already been linked with the development of resistant bacteria. For example, bacteria with reduced susceptibility to triclosan (a NAAM used in hand-wash) were previously found to have […]

Spotlight 18/06/18 | FIEBRE launches first two study sites

The past few weeks, members of the FIEBRE study collaboration have been working together to begin study activities at the first two sites: Harare, Zimbabwe, with colleagues from the Biomedical Research and Training Institute (BRTI), and Chikwawa, Malawi, with the Malawi–Wellcome Trust team. FIEBRE’s primary objectives are to identify the leading infectious causes of fever […]

Spotlight 11/06/18 | Antibiotic resistance and local temperature

A recently-published letter to Nature Climate Change highlighted how crises produced by anthropogenic climate change and antimicrobial resistance might conceivably converge, redrawing geographies of resistance and treatment failure, and adducing potential correspondences with ecosystemic threats. The letter outlines the development of a database of antibiotic resistance patterns in the continental USA, relating to specific infection […]

Spotlight 04/06/18 | Antibiotics Supply is Failing to Meet Demand

The Access to Medicine Foundation has released a new White Paper calling for solutions to a failing antibiotic market. In the work, entitled “Shortages, stockouts and scarcity: the issues facing the security of antibiotic supply and the role for pharmaceutical companies”, they argue that antibiotic supply chains are “on the brink of collapse”, and detail […]

Spotlight 28/05/18 | Drugs, Bugs and our Precarious Existence

This weekend I had the privilege of engaging with Laura Piddock and Ed Whiting and members of the public at the Hay-on-Wye How The Light Gets In Festival. Angela Saini, health journalist, asked us whether it will be possible to defeat antimicrobial resistance, or whether we should come to terms with our precarious existence. I […]

Spotlight 21/05/18 | AMR in agriculture and a new list of essential diagnostic tests

This week has seen two important stories reach the internet – and I am not talking about Yanny/Laurel debate either. This was the highlighting of the problem of AMR in mycology and the release of the WHO list of essential diagnostic test. Rising anti-fungal resistance The recent paper in Science reviewed the problem of antifungal […]

Spotlight 15/05/18 | Mass administration of azithromycin: why, and why not?

Amongst intense attention on stimulating innovation and enforcing stewardship of antibiotics, a recent study—a cluster-randomised trial—highlights just how critical ensuring access to antibiotics is. Published in the New England Journal of Medicine, Keenan et al. reported the efficacy of mass administration of azithromycin, which is known to be effective in reducing rates of trachoma, malaria […]